TACTILE SYSTEMS TECHNOLOGY INC - TCMD
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | — | A | A | 852.0 | 0.0 | 0.0 | 852.0 | View | |
| Feb 26, 2026 | CHIEF FINANCIAL OFFICER | S | D | 7,701.0 | 28.9417 | 222,880.03 | 134,819.0 | View | |
| Feb 26, 2026 | Chief Executive Officer | S | D | 10,993.0 | 28.9406 | 318,144.02 | 243,885.0 | View | |
| Feb 26, 2026 | Sr. VP Mktg & Clinical Affairs | S | D | 6,246.0 | 28.9408 | 180,764.24 | 82,581.0 | View | |
| Feb 24, 2026 | Sr. VP Mktg & Clinical Affairs | S | D | 160.0 | 28.6893 | 4,590.29 | 88,827.0 | View | |
| Feb 24, 2026 | Sr. VP Mktg & Clinical Affairs | S | D | 4,279.0 | 28.2827 | 121,021.67 | 88,987.0 | View | |
| Feb 24, 2026 | Sr. VP Mktg & Clinical Affairs | A | A | 7,123.0 | 0.0 | 0.0 | 93,266.0 | View | |
| Feb 24, 2026 | Sr. VP Mktg & Clinical Affairs | A | A | 4,058.0 | 0.0 | 0.0 | 86,143.0 | View | |
| Feb 24, 2026 | Sr. VP Mktg & Clinical Affairs | A | A | 3,490.0 | 0.0 | 0.0 | 82,085.0 | View | |
| Feb 24, 2026 | Chief Executive Officer | S | D | 537.0 | 28.6891 | 15,406.05 | 254,878.0 | View | |
| Feb 24, 2026 | Chief Executive Officer | S | D | 14,703.0 | 28.2826 | 415,839.07 | 255,415.0 | View | |
| Feb 24, 2026 | Chief Executive Officer | A | A | 28,216.0 | 0.0 | 0.0 | 270,118.0 | View | |
| Feb 24, 2026 | Chief Executive Officer | A | A | 19,751.0 | 0.0 | 0.0 | 241,902.0 | View | |
| Feb 24, 2026 | CHIEF FINANCIAL OFFICER | S | D | 196.0 | 28.6892 | 5,623.08 | 142,520.0 | View | |
| Feb 24, 2026 | CHIEF FINANCIAL OFFICER | S | D | 5,322.0 | 28.2827 | 150,520.53 | 142,716.0 | View | |
| Feb 24, 2026 | CHIEF FINANCIAL OFFICER | A | A | 15,575.0 | 0.0 | 0.0 | 148,038.0 | View | |
| Feb 24, 2026 | CHIEF FINANCIAL OFFICER | A | A | 6,765.0 | 0.0 | 0.0 | 132,463.0 | View | |
| Feb 24, 2026 | CHIEF FINANCIAL OFFICER | A | A | 3,579.0 | 0.0 | 0.0 | 125,698.0 | View | |
| Feb 23, 2026 | Sr. VP Mktg & Clinical Affairs | A | A | 6,194.0 | 0.0 | 0.0 | 78,595.0 | View | |
| Feb 23, 2026 | Chief Executive Officer | A | A | 48,672.0 | 0.0 | 0.0 | 222,151.0 | View | |
| Feb 23, 2026 | CHIEF FINANCIAL OFFICER | A | A | 23,008.0 | 0.0 | 0.0 | 122,119.0 | View | |
| Jan 06, 2026 | Sr. VP Mktg & Clinical Affairs | S | D | 5,139.0 | 28.85 | 148,260.15 | 72,401.0 | View |